Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity

Circulation

Volumn 98, Issue 11, 1998, Pages 1051-1057

  Caplice, Noel M ^a   Mueske, Cheryl S ^a   Kleppe, Laurel S ^a   Simari, Robert D ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

Atherosclerosis; Inhibitor; Plaque; Tissue factor

Indexed keywords

THROMBOPLASTIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE;

EID: 0032530146     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.11.1051     Document Type: Article

References (30)

1. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
2. Nemerson Y. Tissue factor and hemostasis. Blood. 1988;71:1-8.
3. Wilcox J, Smith K, Schwartz S, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86:2839-2843.
4. Drake T, Morrissey J, Edgington T. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
5. Marmur J, Thiruvikraman S, Fyfe B, Guha A, Sharma S, Ambrose J, Fallon J, Nemerson Y, Taubman M. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226-1232.
6. Toschi V, Gallo R, Lettino M, Fallon J, Gertz S, Fernandez-Ortiz A, Chesebro J, Badimon L, Nemerson Y, Fuster V, Badimon J. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997;95:594-599.
7. Tipping P, Malliaros J, Holdswonh S. Procoagulant activity expression by macrophages from atheromatous vascular plaques. Atherosclerosis. 1989;79:237-243.
8. Bajaj M, Kuppuswamy M, Saito H, Spitzer S, Bajaj S, Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci U S A. 1990;87:8869-8873.
9. Lindhout T, Blezer R, Schoen P, Nordfang O, Reutelingsperger C, Hemker H. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Blood. 1992;79:2909-2916.
10. Werling R, Zacharski L, Kisiel W, Bajaj S, Memoli V, Rousseau S. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Thromb Haemost. 1993;69:366-369.
11. vander Logt C, Dirven R, Reitsma P, Bertina R. Expression of tissue factor and tissue factor pathway inhibitors in monocytes in response to bacterial lipopolysaccharide and phorbol ester. Blood Coagul Fibrinol. 1994;5:211-220.
12. Caplice N, Mueske C, Kleppe L, Broze G, Simari R. Expression and regulation of tissue factor pathway inhibitor in arteries and vascular smooth muscle cells. Circulation. 1997;96(suppl I):I-663. Abstract.
13. Bognacki J, Hammelburger J. Functional and immunologic methods for the measurement of human tissue factor pathway inhibitor. Blood Coagul Fibrinol. 1995;6:S65-S72.
14. Carson S, Ross S, Back R, Guha A. An inhibitory monoclonal antibody against human tissue factor. Blood. 1987;70:490-493.
15. Edgington T, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991;66: 67-79.
16. Carson SD, Archer PG. Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reader. Thromb Res. 1986;41:185-195.
17. Sevinsky J, Rao L, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteotysis of the tissue factor-dependent coagulation pathway. J Cell Biochem. 1996;133:293-304.
18. Warn-Cramer B, Maki S. Purification of tissue factor pathway inhibitor (TFPI) from rabbit plasma and characterization of its differences from TFPI isolated from human plasma. Thromb Res. 1992;67:367-383.
19. Rekhter M, Gordon D. Does platelet-derived growth factor-A chain stimulate proliferation of arterial mesenchymal cells in human atherosclerotic plaques? Circ Res. 1994;75:410-417.
20. Sanders N, Bajaj S, Zivelin A, Rapaport S. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood. 1985;66:204-212.
21. Broze G, Warren L, Novotny W, Higuchi D, Girard J, Miletich J. The lipoprotein-associated coagulation inhibitor that inhibits factor Xa: insight into its possible mechanism of action. Blood. 1988;71:335-343.
22. Almus F, Rao L, Rapaport S. Functional properties of factor VIIa/tissue factor performed with purified tissue factor and with tissue factor expressed on cultured endothelial cells. Thromb Haemost. 1989;62: 1067-1073.
23. Callander N, Rao L, Nordfang O, Sandset P, Warn-Cramer B, Rapaport S. Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. J Biol Chem. 1992;267:876-882.
24. Lindahl A, Jacobsen P, Sandset P, Abildgaard U. Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coagul Fibrinol. 1991;2:713-721.
25. Holst J, Lindblad B, Bergqvist D, Nordfang O, Ostergaard P, Petersen J, Nielsen G, Hedner U. Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI I-161) in experimental venous thrombosis: a comparison with low molecular weight heparin. Thromb Haemost. 1994;71:214-219.
26. Haskel E, Torr S, Day K, Palmier M, Wun T, Sobel B, Abendschein D. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation. 1991;84: 821-827.
27. Fernandez-Ortiz A, Badimon J, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah P, Badimon L. Characterization of the relative thrombo-genicity of atherosclerosis plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 1994;23:1562-1569.
28. Hatakeyama K, Asada Y, Marutsuka K, Sato Y, Kamikubo Y, Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis. 1997;133:213-219.
29. Drew A, Davenport P, Apostopoulos J, Tipping P. Tissue factor pathway inhibitor expression in atherosclerosis. Lab Invest. 1997;77:291-298.
30. Zoldhelyi P, McNatt J, Shelat H, Dillard P, Wun T-C, Reese T, Willerson J. Adenovirus-mediated gene transfer of recombinant tissue factor pathway inhibitor in vitro and in vivo. J Am Coll Cardiol. 1998;31:145A. Abstract.